Gallic acid monohydrate, min. 99%, 500 g, plastic packaging.

4-Amino-n-(2-methoxyethyl)benzene-1-sulfonamide, 95%, 100mg

Isoquinoline-6-carbaldehyde, 95.0%, 5g

ISOCONAZOLE NITRATE, 95%, 5g

5-(4-BROMOBENZYL)-2H-TETRAZOLE, 95.0%, 5g

ethyl 5-oxo-5-[4-(thiomorpholinomethyl)phenyl]valerate, 97.0%, 1g

(1S,3R)-3-((tert-Butoxycarbonyl)amino)-2,2-dimethylcyclobutanecarboxylic acid, 97%, 1g

(4-(DIFLUOROMETHOXY)PYRIDIN-2-YL)METHANAMINE HCL, 95%, 50mg

3,5-Bis(trifluoromethyl)phenylhydrazine, 98.0%, 5g

(2S,4R)-1-((S)-14-amino-2-(tert-butyl)-4-oxo-6,9,12-trioxa-3-azatetradecan-1-oyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamidehydrochloride, 95%, 10mg

Boc 4-Acetyl-2-fluoroaniline, 85.0%, 5g

(2,3-dimethylphenyl)(4-phenylpiperazin-1-yl)acetic acid, 1g

2,5-Dichloro-4-methoxypyrimidine, 95.0%, 1g